CN101244220A - Black thorn smilax total saponin extract and preparation method thereof - Google Patents
Black thorn smilax total saponin extract and preparation method thereof Download PDFInfo
- Publication number
- CN101244220A CN101244220A CNA2008100175354A CN200810017535A CN101244220A CN 101244220 A CN101244220 A CN 101244220A CN A2008100175354 A CNA2008100175354 A CN A2008100175354A CN 200810017535 A CN200810017535 A CN 200810017535A CN 101244220 A CN101244220 A CN 101244220A
- Authority
- CN
- China
- Prior art keywords
- extract
- saponin
- chinaroot greenbrier
- black thorn
- smilax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930182490 saponin Natural products 0.000 title claims abstract description 75
- 150000007949 saponins Chemical class 0.000 title claims abstract description 75
- 239000000284 extract Substances 0.000 title claims abstract description 55
- 239000001397 quillaja saponaria molina bark Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 235000010829 Prunus spinosa Nutrition 0.000 title claims description 29
- 240000004350 Prunus spinosa Species 0.000 title claims description 24
- 238000000605 extraction Methods 0.000 title claims description 15
- 241000605422 Asparagus asparagoides Species 0.000 title description 6
- 235000000485 Smilax china Nutrition 0.000 claims abstract description 35
- 239000011347 resin Substances 0.000 claims abstract description 32
- 229920005989 resin Polymers 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000000638 solvent extraction Methods 0.000 claims abstract description 8
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 6
- 238000004440 column chromatography Methods 0.000 claims abstract description 4
- 235000017709 saponins Nutrition 0.000 claims description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 244000261559 Smilax china Species 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 238000010828 elution Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000008504 concentrate Nutrition 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 235000013376 functional food Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000000523 sample Substances 0.000 claims description 4
- 239000012488 sample solution Substances 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 241000234280 Liliaceae Species 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 240000009022 Smilax rotundifolia Species 0.000 claims 17
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims 17
- 239000002253 acid Substances 0.000 claims 2
- 239000003463 adsorbent Substances 0.000 claims 2
- 239000008395 clarifying agent Substances 0.000 claims 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 235000015203 fruit juice Nutrition 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 abstract description 9
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 241001404789 Smilax glabra Species 0.000 abstract 6
- 240000009241 Smilax aspera Species 0.000 description 20
- 241000362909 Smilax <beetle> Species 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 8
- 229930185319 Smilax saponin Natural products 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 244000208734 Pisonia aculeata Species 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- WOJKRRDDERNLBU-BOYSPROGSA-N (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4C(=O)C[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WOJKRRDDERNLBU-BOYSPROGSA-N 0.000 description 4
- HSSJYSJXBOCKQM-GVTGEURHSA-N 22-O-Methylprotodioscin Natural products C([C@H](C)CC[C@]1(OC)[C@H]([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@@H](CC5=CC[C@H]4[C@@H]3C[C@@H]2O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HSSJYSJXBOCKQM-GVTGEURHSA-N 0.000 description 4
- HSSJYSJXBOCKQM-UHFFFAOYSA-N Smilax saponin B Natural products O1C2CC3C4CC=C5CC(OC6C(C(O)C(OC7C(C(O)C(O)C(C)O7)O)C(CO)O6)OC6C(C(O)C(O)C(C)O6)O)CCC5(C)C4CCC3(C)C2C(C)C1(OC)CCC(C)COC1OC(CO)C(O)C(O)C1O HSSJYSJXBOCKQM-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- WOJKRRDDERNLBU-UHFFFAOYSA-N laxogenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4C(=O)CC3C2C2)C)C2OC11CCC(C)CO1 WOJKRRDDERNLBU-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- -1 etc. Substances 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000218158 Clematis Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241001063882 Smilax moranensis Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 238000000105 evaporative light scattering detection Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000003502 gasoline Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 229930002600 steroidal saponin Natural products 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001503367 Smilax japonica Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种从中药黑刺菝葜中提取得到的总皂苷提取物及其制备方法。该提取物主要包括黑刺菝葜皂苷a、黑刺菝葜皂苷b及其类似物。该提取物可由溶剂提取法、溶剂萃取法、大孔吸附树脂法、超临界流体萃取法、柱色谱法、液-液逆流分配色谱法等任意一种方法,或这些方法的任意组合进行制备。所制得的黑刺菝葜总皂苷提取物中总皂苷类成分含量总和为5~100%(W/W),其中黑刺菝葜皂苷a、黑刺菝葜皂苷b及其类似物等成分的含量之和占全部总皂苷含量以重量计为5~100%。The present invention discloses a total saponin extract extracted from the Chinese medicine Smilax china and a preparation method thereof. The extract mainly comprises Smilax china saponin a, Smilax china saponin b and analogs thereof. The extract can be prepared by any one of solvent extraction, solvent extraction, macroporous adsorption resin, supercritical fluid extraction, column chromatography, liquid-liquid countercurrent distribution chromatography, or any combination of these methods. The total content of total saponin components in the obtained Smilax china total saponin extract is 5-100% (W/W), wherein the total content of Smilax china saponin a, Smilax china saponin b and analogs thereof accounts for 5-100% of the total saponin content by weight.
Description
技术领域technical field
本发明涉及一种黑刺菝葜总皂苷提取物及制备方法、质量控制方法及其在医药和保健食品领域的应用,属于医药技术领域。The invention relates to an extract of total saponins from Smilax chinensis, a preparation method, a quality control method and its application in the field of medicine and health food, belonging to the technical field of medicine.
背景技术Background technique
黑刺菝葜(Smilax scobinicaulis C.H.Wright)又名短梗菝葜,是菝葜科菝葜属植物,生于低山灌丛或山谷河岸,主产于陕西、甘肃各省,广泛分布于北方地区,资源十分丰富。其根茎在我国北方代替威灵仙入药,商品上称为“铁丝威灵仙”、“金刚刺”、“金刚藤”等。煎汤或浸酒内服;研粉、磨汁调敷或煎水洗外用;具除风湿、活血解毒、镇惊息风和抗癌等功效,临床上用于治疗风湿性腰腿病、小儿惊风肠炎、瘰疬,疮疖、癌肿等病症。Black thorn smilax (Smilax scobinicaulis C.H.Wright), also known as short-stalked smilax, is a plant of the genus Smilax in the family Smilax. It grows in low mountain shrubs or valley riverbanks. It is mainly produced in Shaanxi and Gansu provinces, and is widely distributed in northern regions. The resources are very rich. Its rhizome is used as medicine instead of Clematis in northern my country, and it is called "wire clematis", "King Kong thorn", "King Kong vine" and so on. Decoction or soaked in wine for oral administration; grinding into powder, grinding juice for application or decocting for external use; it has the functions of eliminating rheumatism, promoting blood circulation and detoxification, calming convulsions and wind and anti-cancer, etc. It is clinically used to treat rheumatic lumbar and leg diseases and infantile convulsions Enteritis, scrofula, boils, cancer and other diseases.
研究发现,黑刺菝葜植物中主要含有甾体皂苷、酚类和甾醇类化学成分,其中皂苷类成分为其主要的活性成分,而且其主要的皂苷成分为含拉肖皂苷元的甾体皂苷及其类似物,是制备拉肖皂苷元(Laxogenin)极好的原料(专利“一种从黑刺菝葜植物中制备拉肖皂苷元的方法”,申请号为200710199224.X)。这些皂苷类成分在其结构中,同时或分别含有羰基、羟基、甲氧基、双键、环氧醚键等活泼官能团,不稳定,在加热(如煎煮等)及植物中酸性成分的双重作用下,易发生结构转化,因此研究黑刺菝葜总皂苷的制备方法具有重要的意义。Studies have found that Smilax nigra plant mainly contains steroidal saponins, phenols and sterols, among which saponins are the main active ingredients, and the main saponins are steroidal saponins containing laxogenin Laxogenin and its analogs are excellent raw materials for the preparation of Laxogenin (patent "a method for preparing Laxogenin from Smilax nigra plant", application number 200710199224.X). These saponin components contain active functional groups such as carbonyl, hydroxyl, methoxy, double bonds, epoxy ether bonds, etc. in their structures at the same time or respectively. Structural transformation is easy to occur under the action of S. blackthorn, so it is of great significance to study the preparation method of total saponins of Smilax nigra.
发明内容Contents of the invention
本发明的目的是提供一种黑刺菝葜总皂苷提取物及其制备方法。本发明提出的黑刺菝葜总皂苷提取物,是从中药黑刺菝葜植物中提取的含有多种皂苷类活性成分的组合,其中主要化合物结构如下:The object of the present invention is to provide a kind of total saponin extract of Smilax chinensis and its preparation method. The total saponins extract of Smilax nigrum provided by the present invention is a combination containing various saponins active ingredients extracted from the plant of Chinese medicine Smilax nigrum, wherein the structure of the main compound is as follows:
本发明所述材料,来源于百合科菝葜属植物黑刺菝葜(Smilax scobinicaulisC.H.Wright)。作为提取黑刺菝葜总皂苷的原材料,可以是市售黑刺菝葜饮片,也可以是黑刺菝葜块根、须根、根茎、茎、卷须和叶子等任一部位或全部植株,其中优选的药材部位为黑刺菝葜干燥根及根茎。上述所述的黑刺菝葜包括未经任何炮制处理的原药材及饮片,还包括各种炮制品。The material of the present invention is derived from Smilax scobinicaulis C.H.Wright, a plant of the genus Smilax in the family Liliaceae. As the raw material for extracting the total saponins of Smilax smilax, it can be commercially available Smilax smilax decoction pieces, or any part or all plants of Smilax smilax tuberous roots, fibrous roots, rhizomes, stems, tendrils and leaves, among which the preferred The part of the medicinal material is the dried root and rhizome of Smilax blackthorn. The above-mentioned Smilax blackthorn includes raw medicinal materials and decoction pieces without any processing, and also includes various processed products.
本发明所述的黑刺菝葜总皂苷提取物,是指从上述植物的任何部位提取得到的,含有多种皂苷类活性成分的组合物。这些皂苷类成分主要包括以下图所示结构为为母核的一系列衍生物:The total saponins extract of Smilax nigra in the present invention refers to a composition obtained by extracting from any part of the above-mentioned plants and containing various saponins active ingredients. These saponins mainly include a series of derivatives with the structure shown in the figure below as the core:
作为黑刺菝葜总皂苷提取物,其中各皂苷类成分百分含量的总和为5~100%(W/W),其中优选的为50~100%(W/W)。As the total saponin extract of Smilax chinensis, the total percentage content of each saponin component is 5-100% (W/W), and preferably 50-100% (W/W).
本发明所述的黑刺菝葜总皂苷提取物所涵盖的各种皂苷类活性成分之中,最主要的是黑刺菝葜皂苷a、黑刺菝葜皂苷b及其类似物等成分。Among the various active ingredients of saponins covered by the total saponin extract of Smilax nigrum according to the present invention, the most important ones are smilax saponin a, smilax saponin b and their analogs.
本发明还提出了黑刺菝葜总皂苷提取物的制备工艺,它可以采用以下任意一种方法,或这些方法的任意组合进行制备:(1)溶剂提取法;(2)溶剂萃取法;(3)大孔吸附树脂法;(4)超临界流体萃取法;(5)柱色谱法;(6)液-液逆流分配色谱法。其中优选的方法为大孔吸附树脂法。The present invention also proposes the preparation process of the total saponin extract of Smilax nigrum, which can be prepared by any one of the following methods, or any combination of these methods: (1) solvent extraction method; (2) solvent extraction method; ( 3) macroporous adsorption resin method; (4) supercritical fluid extraction method; (5) column chromatography; (6) liquid-liquid countercurrent partition chromatography. Among them, the preferred method is the macroporous adsorption resin method.
在使用这些方法进行制备时,一般包括以下几个步骤:When these methods are used for preparation, the following steps are generally included:
(1)提取:所用溶剂可以是水或任意一种醇类、酮类或酯类溶剂,或这些溶剂按一定比例组成的混合溶剂,或由这些溶剂与酸、碱、盐配成的酸性或碱性溶剂。提取方法可以是煎煮、加热回流、超声提取、冷浸、渗漏、微波提取、高压提取等。(1) Extraction: the solvent used can be water or any alcohol, ketone or ester solvent, or a mixed solvent composed of these solvents in a certain proportion, or an acidic or Alkaline solvent. Extraction methods can be decoction, heating reflux, ultrasonic extraction, cold soaking, percolation, microwave extraction, high-pressure extraction, etc.
优选的提取工艺为:黑刺菝葜药材加0~80%乙醇或这些溶剂与碱性物质配成的碱性溶剂,回流提取2~4次,每次提取1~2小时,溶剂用量为5~15倍量(L/kg)。The preferred extraction process is: Add 0-80% ethanol or alkaline solvent made of these solvents and alkaline substances to the medicinal material of Smilax chinensis, and reflux extraction for 2-4 times, each time for 1-2 hours, and the solvent consumption is 5 ~15 times the amount (L/kg).
(2)过滤:包括离心、抽滤、超滤、压滤等方法,使用或不使用以下任意一种澄清剂或其组合:醇沉剂,明胶,高岭土,各种树脂,聚乙二醇,聚乙三醇,壳聚糖以及天然澄清剂成品如101果汁澄清剂、ZTC+1天然澄清剂等。(2) Filtration: including centrifugation, suction filtration, ultrafiltration, pressure filtration, etc., with or without the use of any of the following clarifiers or their combination: alcohol precipitation agent, gelatin, kaolin, various resins, polyethylene glycol, Polyethylene glycol, chitosan and natural clarifier products such as 101 juice clarifier, ZTC+1 natural clarifier, etc.
(3)浓缩:包括常压或减压条件下的薄膜蒸发、旋转蒸发及煎煮浓缩等。(3) Concentration: including thin film evaporation, rotary evaporation and decoction concentration under normal pressure or reduced pressure.
(4)干燥:包括真空干燥、喷雾干燥、冷冻干燥等。(4) Drying: including vacuum drying, spray drying, freeze drying, etc.
当采用萃取法进行制备进行时,一般先将提取物混悬于水中,然后用低极性的酯类、烷烃类或醚类溶剂(如石油醚、乙醚、己烷、汽油、乙酸乙酯等)萃取除去脂溶性杂质,然后用合适的极性溶剂,如氯仿、乙酸乙酯、丙酮、正丁醇等,或是这些溶剂的混合物,萃取获得其中的总皂苷成分,得到总皂苷提取物。When the extraction method is used for preparation, the extract is generally suspended in water first, and then used with low-polarity esters, alkanes or ether solvents (such as petroleum ether, ether, hexane, gasoline, ethyl acetate, etc.) ) extraction to remove fat-soluble impurities, and then use a suitable polar solvent, such as chloroform, ethyl acetate, acetone, n-butanol, etc., or a mixture of these solvents to extract the total saponin components therein to obtain a total saponin extract.
当采用大孔吸附树脂法进行制备时,所用的大孔树脂可以是非极性、弱极性、中等极性、弱碱性或弱酸性等任意一种类型,如D101、D4020、D3500、D941、D21、HP-20、HP-20、XDA-1、AB-8、HPD400、S-8、HZ-806等,其中优选的为弱极性或中等极性的树脂,如AB-8、HPD400、D101等。所用的洗脱剂为水和含水的乙醇、甲醇、丙酮等,其中优选的为70~95%的乙醇。When the macroporous adsorption resin method is used for preparation, the macroporous resin used can be any type of non-polar, weak polar, medium polar, weakly alkaline or weakly acidic, such as D101, D4020, D3500, D941, D21, HP-20, HP-20, XDA-1, AB-8, HPD400, S-8, HZ-806, etc. Among them, weak or medium polar resins are preferred, such as AB-8, HPD400, D101 etc. The eluent used is water and ethanol containing water, methanol, acetone, etc., wherein the preferred ethanol is 70-95%.
优选的黑刺菝葜总皂苷提取物树脂纯化工艺为:选用D101、AB-8、HPD400等中等弱极性或中等极性的树脂作为纯化用树脂,黑刺菝葜提取物上样液稀释倍数1∶5~1∶18(以生药量计),吸附流速2~9BV/h,树脂柱径高比1∶3~1∶10,上样量为0.1~0.5g/mL(以生药量计),0~10%乙醇洗脱1~5倍树脂体积进行除杂,除杂流速为2~7BV/h,用60~95%乙醇洗脱3~10倍树脂体积,洗脱流速为2~9BV/h。The preferred resin purification process of the total saponins extract of Smilax nigra is as follows: select D101, AB-8, HPD400 and other medium weak polarity or medium polar resins as the resin for purification, and the dilution ratio of the sample solution of the Smilax nigra extract 1:5~1:18 (based on the crude drug amount), the adsorption flow rate is 2~9BV/h, the resin column diameter-to-height ratio is 1:3~1:10, and the sample loading is 0.1~0.5g/mL (based on the crude drug amount ), 0-10% ethanol elutes 1-5 times the resin volume for impurity removal, the impurity removal flow rate is 2-7BV/h, and 3-10 times the resin volume is eluted with 60-95% ethanol, and the elution flow rate is 2-7BV/h 9BV/h.
当采用超临界流体萃取法进行制备时,可以对黑刺菝葜原料直接进行萃取,也可以对上述任一方法和步骤所获得的产物进行萃取。萃取时可以使用或不使用以下任一种类溶剂及溶剂混合物:水、醇类、酮类及酯类溶剂。When supercritical fluid extraction is used for preparation, the raw material of Smilax nigra can be directly extracted, or the product obtained by any of the above methods and steps can be extracted. Extraction can be performed with or without any of the following solvents and solvent mixtures: water, alcohols, ketones, and esters.
当采用柱色谱法进行制备时,其处理的对象可以是上述提取步骤所获得的产物,也可以是经上述溶剂提取法、大孔吸附树脂法或超临界流体萃取法初步纯化后的产物。所用的固定相可以是硅胶、聚酰胺、氧化铝、葡聚糖(Sephadex系列或Sephadex-20系列)、C-8、C-18、活性碳、纤维素等,所用的洗脱液因固定相的不同而不同,一般是水、甲醇、乙醇、丙酮、氯仿、乙酸乙酯、石油醚等组成的混合溶剂。When column chromatography is used for preparation, the object of treatment may be the product obtained in the above extraction step, or the product preliminarily purified by the above solvent extraction method, macroporous adsorption resin method or supercritical fluid extraction method. The stationary phase used can be silica gel, polyamide, aluminum oxide, dextran (Sephadex series or Sephadex-20 series), C-8, C-18, activated carbon, cellulose, etc., and the eluent used varies depending on the stationary phase. It varies with different solvents, and it is generally a mixed solvent composed of water, methanol, ethanol, acetone, chloroform, ethyl acetate, petroleum ether, etc.
当采用液-液逆流萃取法进行制备时,其处理的对象可以是上述提取步骤的产物,也可以是经上述溶剂提取法、大孔吸附树脂法或超临界流体萃取法初步纯化后的产物。一般是将提取物混悬于水中,然后用低极性的酯类、烷烃类或醚类溶剂(如石油醚、乙醚、己烷、汽油、乙酸乙酯等)萃取除去脂溶性杂质,然后用合适极性的溶剂,如氯仿、乙酸乙酯、丙酮、正丁醇等,或是这些溶剂的混合物,萃取获得其中的总皂苷成分,得总皂苷提取物。When the liquid-liquid countercurrent extraction method is used for preparation, the object of treatment can be the product of the above extraction step, or the product that has been preliminarily purified by the above solvent extraction method, macroporous adsorption resin method or supercritical fluid extraction method. Generally, the extract is suspended in water, and then extracted with low-polarity esters, alkanes or ether solvents (such as petroleum ether, ether, hexane, gasoline, ethyl acetate, etc.) to remove fat-soluble impurities, and then use A suitable polar solvent, such as chloroform, ethyl acetate, acetone, n-butanol, etc., or a mixture of these solvents, is extracted to obtain the total saponin components therein to obtain a total saponin extract.
该提取物可以单独或与其它任何中西药或食物按任意比例配伍,用于制备药物或功能性食品,所得的药物或功能性食品可以是胶囊剂、片剂、丸剂、颗粒剂、口服液、糖浆、冲剂、酒剂、注射剂、膏剂、散剂、饮料等。The extract can be used alone or in combination with any other Chinese and Western medicine or food in any proportion to prepare medicine or functional food. The obtained medicine or functional food can be in the form of capsules, tablets, pills, granules, oral liquid, Syrups, granules, liquors, injections, ointments, powders, beverages, etc.
本发明质量控制方法可包括以下含量测定方法中的一种或两种:The quality control method of the present invention may include one or both of the following assay methods:
1.溶血指数法测定皂苷含量1. Determination of saponin content by hemolytic index method
0.5%药材浸出液的配制:黑刺菝葜药材粉末以等渗磷酸盐缓冲液(或生理食盐水)精确配制成0.5%浓度。Preparation of 0.5% medicinal extract: the medicinal powder of Smilax blackthorn is precisely prepared with isotonic phosphate buffer (or physiological saline) to a concentration of 0.5%.
溶血指数的测定:取直径、长短一致的9支小试管,分别精确吸入0.1、0.2、0.3、……0.9mL黑刺菝葜提取物,精密加缓冲液补足体积为1mL,各试管中再各精密加1mL 2%血球悬浮液,各管摇匀后由可以产生完全溶血的黑刺菝葜提取物最低浓度来计算溶血指数。Determination of hemolytic index: Take 9 small test tubes with the same diameter and length, accurately inhale 0.1, 0.2, 0.3, ... 0.9mL of Smilax japonica extract, add buffer to make up the volume to 1mL, and add each Accurately add 1mL of 2% blood cell suspension, shake each tube well and calculate the hemolysis index from the lowest concentration of Smilax nigra extract that can produce complete hemolysis.
皂苷含量的测定:用标准皂苷黑刺菝葜皂苷a或黑刺菝葜皂苷b配成适当浓度的溶液,同上法测定溶血指数,从标准皂苷与黑刺菝葜提取物的溶血指数计算黑刺菝葜皂苷的百分含量。Determination of saponin content: use the standard saponin Smilax saponin a or Smilax saponin b to prepare a solution of appropriate concentration, measure the hemolytic index with the same method as above, and calculate the black thorn The percentage content of smilax saponins.
2.HPLC-ELSD法分析黑刺菝葜皂苷的含量2. HPLC-ELSD analysis of the content of smilax saponins in blackthorn
色谱条件:蒸发光散射检测器,色谱柱:反相C18(4.6×150mm,5μm);流动相:乙腈-水梯度洗脱,40~80%(0~70min);流速:1.0mL/Min;柱温:25℃。Chromatographic conditions: evaporative light scattering detector, chromatographic column: reversed-phase C18 (4.6×150mm, 5μm); mobile phase: acetonitrile-water gradient elution, 40-80% (0-70min); flow rate: 1.0mL/Min; Column temperature: 25°C.
标准曲线绘制:分别精密吸取黑刺菝葜标准皂苷黑刺菝葜皂苷a或黑刺菝葜皂苷b对照品溶液(1.0μg/μL)0、2、5、10、15、20μL注入液相色谱仪,测定各色谱峰峰面积,以对照进样量(μg)为横坐标,色谱峰面积为纵坐标,绘制标准曲线。Standard curve drawing: 0, 2, 5, 10, 15, 20 μL of reference substance solution (1.0 μg/μL) of Smilax saponin standard saponin Smilax saponin a or Smilax saponin b (1.0 μg/μL) was drawn precisely and injected into liquid chromatography Instrument, measure the peak area of each chromatographic peak, take the control injection volume (μg) as the abscissa, and the chromatographic peak area as the ordinate, draw the standard curve.
含量测定:精密称取3批黑刺菝葜提取物样品各3份,每份约20mg,置于10mL量瓶中,加70%乙醇超声溶解,并稀释至刻度,摇匀,作为黑刺菝葜皂苷含量测定的供试样品溶液,精密吸取上述供试样品溶液20μL注入液相色谱仪,测定各色谱峰峰面积,计算含量。Content determination: Accurately weigh 3 batches of 3 batches of Smilax nigra extract samples, each about 20mg, put them in a 10mL measuring bottle, add 70% ethanol to ultrasonically dissolve, dilute to the scale, shake well, and use as Smilax nigrum For the test sample solution for the determination of the saponin content, 20 μL of the above-mentioned test sample solution was precisely drawn and injected into the liquid chromatograph, and the area of each chromatographic peak was measured to calculate the content.
具体实施方式:Detailed ways:
实施例1:黑刺菝葜总皂苷提取物制备工艺Example 1: Preparation process of total saponins extract of Smilax chinensis
取黑刺菝葜根茎1kg,干燥,研磨成粗粉,加入4L 70%乙醇(V/V)溶液室温浸提4次,每次4h,合并提取液,将滤液浓缩成浸膏,加水分散溶解,使水溶液稀释倍数为1∶15(以生药量计),依次用等体积的石油醚、正丁醇分别萃取5次,分别减压回收溶剂得萃取物。正丁醇萃取物用去离子水溶解,按照样品与填料1∶7比例在D-101型大孔树脂上纯化,先用去离子水洗脱除杂,直至α-萘酚反应检测洗脱液成阴性为止,除杂流速为3BV/h,然后用90%乙醇洗脱8倍树脂体积,洗脱流速为2BV/h,收集90%乙醇洗脱液,回收乙醇,减压干燥得黑刺菝葜总皂苷提取物。测定黑刺菝葜总皂苷提取物中总皂苷含量为54%,测定黑刺菝葜皂苷a和黑刺菝葜皂苷b两种成分的含量之和为40%。Take 1kg of the rhizome of Smilax chinensis, dry it, grind it into a coarse powder, add 4L 70% ethanol (V/V) solution at room temperature to extract 4 times, 4 hours each time, combine the extracts, concentrate the filtrate into an extract, add water to disperse and dissolve , so that the dilution ratio of the aqueous solution is 1:15 (based on the amount of crude drug), it is extracted 5 times with an equal volume of petroleum ether and n-butanol successively, and the solvent is recovered under reduced pressure to obtain the extract. The n-butanol extract was dissolved in deionized water, and purified on D-101 macroporous resin according to the ratio of sample to filler of 1:7. Until negative, the impurity removal flow rate is 3BV/h, then 8 times the resin volume is eluted with 90% ethanol, the elution flow rate is 2BV/h, the 90% ethanol eluate is collected, the ethanol is recovered, and dried under reduced pressure to obtain Smilax chinensis Total Saponin Extract. The content of total saponins in the total saponin extract of Smilax nigra was determined to be 54%, and the sum of the content of the two components of Smilax nigra saponin a and Smilax nigra saponin b was determined to be 40%.
实施例2:黑刺菝葜总皂苷提取物制备工艺Example 2: Preparation process of total saponins extract of Smilax chinensis
取黑刺菝葜茎1kg,粉碎,加水煮沸提取三次并控制酸碱度,第一次为药材量的8倍水量和0.7%药材量的NaCO3,第二次为药材量的5倍水量和0.3%药材量的NaCO3,第三次为药材量的4倍水量;逆流循环提取,沸后分别保持1.5、1、1小时;药液合并并冷至室温,过滤,滤液上已处理好的大孔型弱碱性阴离子D392交换柱,用2倍树脂床体积的2%NaOH溶液冲洗,冲洗液弃去,再用3倍纯水冲洗,水冲洗液弃去;用7倍树脂床体积的70%醇洗脱,收集洗脱液,浓缩至稠膏(50℃下相对密度为1.28~1.33)干燥,得黑刺菝葜总皂苷提取物。测定黑刺菝葜总皂苷提取物中总皂苷含量为64%,测定黑刺菝葜皂苷a和黑刺菝葜皂苷b两种成分的含量之和为45%。Take 1kg of the stem of Smilax chinensis, crush it, add water to boil and extract three times and control the pH, the first time is 8 times the amount of water and 0.7% NaCO 3 of the amount of the drug, and the second time is 5 times the amount of water and 0.3% of the amount of the drug The amount of NaCO 3 in the amount of medicinal materials, the third time is 4 times the amount of water; countercurrent circulation extraction, after boiling, keep for 1.5, 1, and 1 hour respectively; the medicinal liquids are combined and cooled to room temperature, filtered, and the treated macropores on the filtrate Type weakly basic anion D392 exchange column, rinse with 2% NaOH solution 2 times the volume of the resin bed, discard the rinse solution, then rinse with 3 times pure water, discard the water rinse solution; use 70% of the resin bed volume 7 times eluate with alcohol, collect the eluate, concentrate to a thick paste (relative density at 50°C is 1.28-1.33) and dry to obtain the total saponin extract of Smilax nigra. The total saponin content in the total saponin extract of Smilax nigra was determined to be 64%, and the sum of the content of the two components of Smilax nigra saponin a and Smilax nigra saponin b was determined to be 45%.
实施例3:黑刺菝葜总皂苷提取物制备工艺Example 3: Preparation process of total saponins extract from Smilax chinensis
取黑刺菝葜根粉1kg,加入12倍量95%的乙醇,回流提取3次,每次提取3小时,合并乙醇提取液,回收乙醇,浓缩至干,然后加入8倍量的去离子水搅拌溶解,将溶液通过AB-8型大孔吸附树脂层析柱,吸附流速4BV/h,数值柱径高比为1∶9,上样量为0.1g/mL(以生药量计);用水洗剂树脂12BV,洗脱流速为6BV/h,冲洗液弃去;用90%乙醇洗脱8倍树脂体积,洗脱流速为5BV/h,收集乙醇洗脱液,回收乙醇,减压干燥得黑刺菝葜总皂苷提取物。测定黑刺菝葜总皂苷提取物中总皂苷含量为65%,测定黑刺菝葜皂苷a和黑刺菝葜皂苷b两种成分的含量之和为53%。Get 1 kg of Smilax nigra root powder, add 12 times the amount of 95% ethanol, reflux extraction 3 times, extract 3 hours each time, combine the ethanol extract, reclaim the ethanol, concentrate to dryness, then add 8 times the amount of deionized water Stir and dissolve, the solution is passed through the AB-8 type macroporous adsorption resin chromatography column, the adsorption flow rate is 4BV/h, the numerical column diameter-to-height ratio is 1:9, and the sample loading is 0.1g/mL (based on crude drug amount); Water lotion resin 12BV, the elution flow rate is 6BV/h, the washing solution is discarded; 8 times the resin volume is eluted with 90% ethanol, the elution flow rate is 5BV/h, the ethanol eluate is collected, the ethanol is recovered, and dried under reduced pressure to obtain Blackthorn Smilax total saponin extract. The content of total saponins in the total saponin extract of Smilax nigra was determined to be 65%, and the sum of the contents of the two components of Smilax nigra saponin a and Smilax nigra saponin b was determined to be 53%.
实施例4:黑刺菝葜总皂苷片的制备Example 4: Preparation of Smilax chinensis Total Saponins Tablets
黑刺菝葜总皂苷提取物10gBlackthorn Smilax total saponins extract 10g
淀粉 10gStarch 10g
上述组分混合均匀,加滑石粉适量,压制成100片。The above components are mixed evenly, and an appropriate amount of talcum powder is added, and pressed into 100 tablets.
实施例5:黑刺菝葜总皂苷复方制剂的制备Example 5: Preparation of the compound preparation of total saponins of Smilax chinensis
黑刺菝葜总皂苷提取物30gBlackthorn Smilax total saponins extract 30g
半技莲水提取物 30gBanji lotus water extract 30g
白花蛇舌草水提取物 30gHedyotis diffusa water extract 30g
上述组分混合均匀,装入硬明胶胶囊中,共360粒胶囊。The above components are mixed evenly, and packed into hard gelatin capsules, 360 capsules in total.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100175354A CN101244220A (en) | 2008-02-22 | 2008-02-22 | Black thorn smilax total saponin extract and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100175354A CN101244220A (en) | 2008-02-22 | 2008-02-22 | Black thorn smilax total saponin extract and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101244220A true CN101244220A (en) | 2008-08-20 |
Family
ID=39945042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100175354A Pending CN101244220A (en) | 2008-02-22 | 2008-02-22 | Black thorn smilax total saponin extract and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101244220A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102007923A (en) * | 2010-11-19 | 2011-04-13 | 西北农林科技大学 | Laxogenin and derivative thereof-containing plant growth regulator and application thereof |
CN106975035A (en) * | 2017-04-05 | 2017-07-25 | 怀化正好制药有限公司 | Cloudy itching-relieving lotion of a kind of novel cleaning and preparation method thereof |
-
2008
- 2008-02-22 CN CNA2008100175354A patent/CN101244220A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102007923A (en) * | 2010-11-19 | 2011-04-13 | 西北农林科技大学 | Laxogenin and derivative thereof-containing plant growth regulator and application thereof |
CN106975035A (en) * | 2017-04-05 | 2017-07-25 | 怀化正好制药有限公司 | Cloudy itching-relieving lotion of a kind of novel cleaning and preparation method thereof |
CN106975035B (en) * | 2017-04-05 | 2018-06-29 | 怀化正好制药有限公司 | A kind of clean cloudy itching-relieving lotion and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101336978B (en) | A kind of extraction method of Hovenia dulcis total flavonoids | |
CN101336987B (en) | Preparation method of total flavone of Hovenia dulcisThunb | |
CN108619202B (en) | A kind of method for extraction of deep eutectic solvent and separation and purification of total flavonoids of burdock leaves with macroporous adsorption resin | |
CN101073599B (en) | Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production | |
CN101062165B (en) | Citrus aurantium total flavone extract and the preparing method thereof | |
CN101073595B (en) | Glycyrrhiza total flavonoid and total saponin extract and its production | |
CN101062128B (en) | Extract of total glucosides of paeony and the preparing method thereof | |
CN101062077B (en) | Method for preparing stevia whole stevioside and stevia whole flavone at the same time | |
CN101062071B (en) | Total saponins from radix bupleuri extract and the preparing method thereof | |
CN101085041B (en) | Total alkaloid of lotus leaves extraction and its preparation method | |
CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
CN101229335A (en) | Method for Enzymatically Preparing Smilax Smilax Total Saponins Extract | |
CN101401829A (en) | Wild Jinchai active extract and preparation method and application thereof | |
CN112159451A (en) | Gynostemma pentaphylla saponin extract and preparation method thereof | |
CN101347491A (en) | Radical lobelia total flavones effective component and preparation thereof | |
CN101234147A (en) | Preparation method of total flavonoids from Trollus chinensis for injection | |
CN107929544B (en) | Preparation method and application of mileanine part and monomer in bletilla plants | |
CN101474350B (en) | Method for extracting total saponin in asparagus and use thereof | |
CN101244220A (en) | Black thorn smilax total saponin extract and preparation method thereof | |
CN113429442B (en) | Method for separating tectoridin and tectorigenin from water extraction residues of rhizoma et radix Sichuan blackberry lily | |
CN112250655B (en) | Two new cyclic diphenylheptane compounds and their preparation method and use | |
CN110433199B (en) | Traditional Chinese medicine composition with components of tonifying qi, activating blood and detoxifying for treating cerebral ischemia and preparation method thereof | |
CN110776541B (en) | Preparation method and application of quercetin-3-gentiobioside | |
CN102670935A (en) | Method for extracting total saponins from allium chinense | |
CN104435658B (en) | A kind of medicine for ischemia apoplexy prevention and treatment and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080820 |